Patent · US Active

Indole derivatives

US7342030B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Thomas Friess · Planegg, DE
Ulrike Reiff · Penzberg, DE
Matthias Rueth · Penzberg, DE
Edgar Voss · Bichl, DE

Key dates

Filing date	Sep 20, 2005
Grant date	Mar 11, 2008
Priority date	—
Expiry date	Jun 20, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to the compounds of formula I:their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing such compounds and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.